Company: ISRG
Filing Date: 2025-10-22
Form Type: 10-Q
Source: 0001035267-25-000209
Chunk: 3

Company: INTUITIVE SURGICAL INC
Filing Date: 2025-10-22
Form: 10-Q
Item: Item 1
Chunk 3
---
.6 Gain on investments, accretion of discounts, and amortization of premiums on investments, net(42.3)(38.2)Deferred income taxes58.6 (104.5)Share-based compensation expense584.9 499.8 Amortization of contract acquisition assets27.4 27.0 Changes in operating assets and liabilities, net of effects of acquisitions:Accounts receivable(34.2)(21.8)Inventory(810.4)(650.9)Prepaids and other assets(248.9)(79.6)Accounts payable97.0 21.2 Accrued compensation and employee benefits(80.2)(58.9)Deferred revenue47.6 (6.1)Other liabilities5.2 17.6 Net cash provided by operating activities2,138.0 1,592.4 Investing activities:Purchase of investments(790.9)(3,709.6)Proceeds from sales of investments249.1 100.2 Proceeds from maturities of investments1,795.5 2,400.0 Purchase of property, plant, and equipment(377.3)(799.2)Acquisition of businesses, net of cash, and intellectual property and other investing activities(1.2)— Net cash provided by (used in) investing activities875.2 (2,008.6)Financing activities:Proceeds from issuance of common stock relating to employee stock plans273.7 367.5 Taxes paid related to net share settlement of equity awards(406.0)(257.5)Repurchase of common stock(2,094.3)— Cash dividends paid by joint venture to noncontrolling interest— (8.0)Payment of deferred purchase consideration— (0.5)Net cash provided by (used in) financing activities(2,226.6)101.5 Effect of exchange rate changes on cash, cash equivalents, and restricted cash0.5 (9.1)Net increase (decrease) in cash, cash equivalents, and restricted cash787.1 (323.8)Cash, cash equivalents, and restricted cash, beginning of period2,062.4 2,770.1 Cash, cash equivalents, and restricted cash, end of period$2,849.5 $2,446.3 

The accompanying notes are an integral part of these